Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Gil R, Diogo"'
Autor:
Andy C. Tran, Gil R. Diogo, Matthew J. Paul, Alastair Copland, Peter Hart, Nickita Mehta, Edward. B. Irvine, Tufária Mussá, Pascal M. W. Drake, Juraj Ivanyi, Galit Alter, Rajko Reljic
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
New evidence has been emerging that antibodies can be protective in various experimental models of tuberculosis. Here, we report on protection against multidrug-resistant Mycobacterium tuberculosis (MDR-TB) infection using a combination of the human
Externí odkaz:
https://doaj.org/article/571ab20885874bdbbf5051fa15c6f248
Autor:
Gil R. Diogo, Peter Hart, Alastair Copland, Mi-Young Kim, Andy C. Tran, Noemi Poerio, Mahavir Singh, Matthew J. Paul, Maurizio Fraziano, Rajko Reljic
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Liposomes have been long considered as a vaccine delivery system but this technology remains to be fully utilized. Here, we describe a novel liposome-based subunit vaccine formulation for tuberculosis (TB) based on phosphatidylserine encapsulating tw
Externí odkaz:
https://doaj.org/article/d0122b763aaf41bda98761dfb1de1ffd
Autor:
Alastair Copland, Gil R. Diogo, Peter Hart, Shane Harris, Andy C. Tran, Mathew J. Paul, Mahavir Singh, Simon M. Cutting, Rajko Reljic
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Tuberculosis (TB) is the most deadly infectious disease in existence, and the only available vaccine, Bacillus Calmette-Guérin (BCG), is almost a century old and poorly protective. The immunological complexity of TB, coupled with rising resistance t
Externí odkaz:
https://doaj.org/article/acf7f50e56c84b2e9529d6c74ab4aa34
Autor:
Rajko Reljic, Mathew J. Paul, Gina R. Webster, Sven Hofmann, Thais Guerra, Szymon Stelter, Gil R. Diogo, Audrey Y.-H. Teh, Alastair Copland, Peter Hart, Julian K.-C. Ma, Craig J. van Dolleweerd, Mi-Young Kim
Publikováno v:
Plant Biotechnology Journal
Summary In this study, a strategy based on polymeric immunoglobulin G scaffolds (PIGS) was used to produce a vaccine candidate for Mycobacterium tuberculosis. A genetic fusion construct comprising genes encoding the mycobacterial Ag85B antigen, an im
Autor:
Gil R. Diogo, Szymon Stelter, Pascal M. W. Drake, Peter Hart, Matthew J. Paul, Alastair Copland, Craig J. van Dolleweerd, Rajko Reljic, Derek C. Macallan, Adam Sparrow
Publikováno v:
Cytokine
IL-4 is a pleiotropic cytokine that is highly Th2 polarizing. The ratio of IL-4 and its splice variant IL-4Δ2 observed in human health and disease suggests a role for both isoforms. In the present study, the biological function of murine IL-4Δ2 and
Autor:
Matthew J. Paul, Peter Hart, Alastair Copland, Mahavir Singh, Noemi Poerio, Rajko Reljic, Maurizio Fraziano, Gil R. Diogo, Mi-Young Kim, Andy C. Tran
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Frontiers in Immunology
Liposomes have been long considered as a vaccine delivery system but this technology remains to be fully utilized. Here, we describe a novel liposome-based subunit vaccine formulation for tuberculosis (TB) based on phosphatidylserine encapsulating tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945481161c8b9f7e41ad971bd4e78b42
http://hdl.handle.net/2108/241643
http://hdl.handle.net/2108/241643
Autor:
Kaustuv Nayak, Rajko Reljic, Qibo Zhang, Muhammad S Ahmed, Anmol Chandele, Alastair Copland, Matthew J. Paul, Julian K.-C. Ma, Gil R. Diogo, Moon-Sik Yang, Yong-Suk Jang, Sven Hofmann, Mi-Young Kim
Publikováno v:
PLANT BIOTECHNOLOGY JOURNAL
Plant Biotechnology Journal
Plant Biotechnology Journal
Dengue is a major global disease requiring improved treatment and prevention strategies. The recently licensed Sanofi-Pasteur Denvaxia vaccine does not protect children under the age of nine and additional vaccine strategies are thus needed to halt t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e01c1d96c8b370ee5e9c89f158587e3
Autor:
Miyuki Azuma, Adam Sparrow, Mathew J. Paul, Alastair Copland, Rajko Reljic, Peter Hart, Gil R. Diogo
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Bacillus Calmette-Guérin (BCG) is the only licensed vaccine for tuberculosis (TB), and is also used as an immunotherapy for bladder cancer and other malignancies due to its immunostimulatory properties. Mycobacteria spp., however, are well known for
Autor:
Peter Hart, Mahavir Singh, Gil R. Diogo, Andy C. Tran, Rajko Reljic, Shane Harris, Mathew J. Paul, Simon M. Cutting, Alastair Copland
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Tuberculosis (TB) is the most deadly infectious disease in existence, and the only available vaccine, Bacillus Calmette-Guérin (BCG), is almost a century old and poorly protective. The immunological complexity of TB, coupled with rising resistance t
Autor:
Alastair, Copland, Gil R, Diogo, Peter, Hart, Shane, Harris, Andy C, Tran, Mathew J, Paul, Mahavir, Singh, Simon M, Cutting, Rajko, Reljic
Publikováno v:
Frontiers in Immunology
Tuberculosis (TB) is the most deadly infectious disease in existence, and the only available vaccine, Bacillus Calmette-Guérin (BCG), is almost a century old and poorly protective. The immunological complexity of TB, coupled with rising resistance t